SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001047469-98-021654
Filing Date
1998-05-22
Accepted
1998-05-22 00:00:00
Documents
1
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 18960
  Complete submission text file 0001047469-98-021654.txt   20920
Mailing Address 117 FOURTH AVE NEEDHAM MA 02194
Business Address 117 FOURTH AVE NEEDHAM MA 02194 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-38071 | Film No.: 98630962
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice